These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3540031)

  • 1. Renal cyclosporine clearance in marrow transplant recipients: age-related variation.
    Yee GC; Mills G; Schaffer R; Lennon TP; Kennedy MS; Deeg HJ
    J Clin Pharmacol; 1986; 26(8):658-61. PubMed ID: 3540031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood cyclosporine pharmacokinetics in patients undergoing marrow transplantation. Influence of age, obesity, and hematocrit.
    Yee GC; McGuire TR; Gmur DJ; Lennon TP; Deeg HJ
    Transplantation; 1988 Sep; 46(3):399-402. PubMed ID: 3047931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent cyclosporine: pharmacokinetics in marrow transplant recipients.
    Yee GC; Lennon TP; Gmur DJ; Kennedy MS; Deeg HJ
    Clin Pharmacol Ther; 1986 Oct; 40(4):438-43. PubMed ID: 3530588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of serum cyclosporine concentration with renal dysfunction in marrow transplant recipients.
    Kennedy MS; Yee GC; Mcguire TR; Leonard TM; Crowley JJ; Deeg HJ
    Transplantation; 1985 Sep; 40(3):249-53. PubMed ID: 3898489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of H2-receptor antagonists on renal function in cyclosporine-treated renal transplant patients.
    Pachon J; Lorber MI; Bia MJ
    Transplantation; 1989 Feb; 47(2):254-9. PubMed ID: 2645708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal risk of chronic renal dysfunction in marrow transplant recipients treated with cyclosporine for 6 months.
    Yee GC; McGuire TR; St Pierre BA; Self SG; Zager RA; Sullivan KM; Deeg HJ
    Bone Marrow Transplant; 1989 Nov; 4(6):691-4. PubMed ID: 2684309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine monitoring improves graft-versus-host disease prophylaxis after bone marrow transplantation.
    Ghalie R; Fitzsimmons WE; Weinstein A; Manson S; Kaizer H
    Ann Pharmacother; 1994 Mar; 28(3):379-83. PubMed ID: 8193430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of intravenous cyclosporine in bone marrow transplant patients. Comparison of two assay methods.
    Yee GC; Kennedy MS; Storb R; Thomas ED
    Transplantation; 1984 Nov; 38(5):511-3. PubMed ID: 6388073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine in human bone marrow transplantation. Serum concentration, graft-versus-host disease, and nephrotoxicity.
    Gratwohl A; Speck B; Wenk M; Forster I; Müller M; Osterwalder B; Nissen C; Follath F
    Transplantation; 1983 Jul; 36(1):40-4. PubMed ID: 6346614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the clinical utility of the radioimmunoassay, high-performance liquid chromatography, and TDx cyclosporine assays in outpatient renal transplant recipients.
    Schroeder TJ; Brunson ME; Pesce AJ; Hindenlang LL; Mauser PA; Ruckrigl DI; Weibel ML; Wadih G; First MR
    Transplantation; 1989 Feb; 47(2):262-6. PubMed ID: 2645710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic cyclosporine-associated nephrotoxicity in bone marrow transplant patients.
    Dieterle A; Gratwohl A; Nizze H; Huser B; Mihatsch MJ; Thiel G; Tichelli A; Signer E; Nissen C; Speck B
    Transplantation; 1990 Jun; 49(6):1093-100. PubMed ID: 2193442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: serial renal function in heart and kidney transplant recipients.
    Lewis RM; Van Buren CT; Radovancevic B; Frazier OH; Janney RP; Powers PL; Golden DL; Giannakis JG; Macris MP; Kerman RH
    J Heart Lung Transplant; 1991; 10(1 Pt 1):63-70. PubMed ID: 2007172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic studies of cyclosporine in marrow transplant recipients. A comparison of three assay methods.
    McGuire TR; Yee GC; Emerson S; Gmur DJ; Carlin J
    Transplantation; 1992 Jun; 53(6):1272-5. PubMed ID: 1604484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function outcome in pediatric liver transplant recipients.
    Mention K; Lahoche-Manucci A; Bonnevalle M; Pruvot FR; Declerck N; Foulard M; Gottrand F
    Pediatr Transplant; 2005 Apr; 9(2):201-7. PubMed ID: 15787794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six weeks of continuous intravenous cyclosporine and short-course methotrexate as prophylaxis for acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Beelen DW; Quabeck K; Kaiser B; Wiefelspütz J; Scheulen ME; Graeven U; Grosse-Wilde H; Sayer HG; Schaefer UW
    Transplantation; 1990 Sep; 50(3):421-7. PubMed ID: 2402791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring cyclosporin concentrations in marrow transplant recipients: comparison of two assay methods.
    Yee GC; Kennedy MS; Gmur DJ; Self SG; Deeg HJ
    Bone Marrow Transplant; 1987 Feb; 1(3):289-95. PubMed ID: 3332139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute renal toxicity with combined use of amphotericin B and cyclosporine after marrow transplantation.
    Kennedy MS; Deeg HJ; Siegel M; Crowley JJ; Storb R; Thomas ED
    Transplantation; 1983 Mar; 35(3):211-5. PubMed ID: 6340275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantation.
    Yee GC; Self SG; McGuire TR; Carlin J; Sanders JE; Deeg HJ
    N Engl J Med; 1988 Jul; 319(2):65-70. PubMed ID: 3288872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone.
    Moran M; Mozes MF; Maddux MS; Veremis S; Bartkus C; Ketel B; Pollak R; Wallemark C; Jonasson O
    N Engl J Med; 1990 Apr; 322(17):1183-8. PubMed ID: 2109195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation.
    Lindholm A; Dahlqvist R; Groth GG; Sjöqvist F
    Br J Clin Pharmacol; 1990 Sep; 30(3):443-52. PubMed ID: 2223423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.